Tepmetko Den Europæiske Union - dansk - EMA (European Medicines Agency)

tepmetko

merck europe b.v. - tepotinib hydrochloride monohydrate - carcinom, ikke-småcellet lunge - antineoplastiske midler - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Erlotinib "Stada" 100 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 100 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 100 mg

Erlotinib "Stada" 150 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 150 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 150 mg

Erlotinib "Stada" 25 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

erlotinib "stada" 25 mg filmovertrukne tabletter

stada arzneimittel ag - erlotinibhydrochlorid - filmovertrukne tabletter - 25 mg